Cingulate Receives Complete Response Letter from FDA for CTx-1301
Cingulate Inc. No Clinical Safety or Efficacy Concerns Currently Identified Agency Feedback Primarily Focused on CMC-Related RequestsCompany Plans Prompt…
US FDA declines to approve Cingulate’s ADHD drug
June 2 (Reuters) – Cingulate said on Tuesday that the U.S. Food and Drug Administration declined to approve…